EGFR and cancer: EVs released by cancer cell lines such as A549, HepG2, MCF10A, and MCF-7 prolonged monocyte survival, prompting the development of tumor-associated macrophages (TAM) via the transfer of phosphorylated EGFR, thus promoting an inflammatory microenvironment[159].